231 related articles for article (PubMed ID: 30877466)
1. Renal cell carcinoma: predicting RUNX3 methylation level and its consequences on survival with CT features.
Cen D; Xu L; Zhang S; Chen Z; Huang Y; Li Z; Liang B
Eur Radiol; 2019 Oct; 29(10):5415-5422. PubMed ID: 30877466
[TBL] [Abstract][Full Text] [Related]
2. Renal Cell Carcinoma: Predicting DNA Methylation Subtyping and Its Consequences on Overall Survival With Computed Tomography Imaging Characteristics.
Yu T; Lin C; Li X; Quan X
J Comput Assist Tomogr; 2020; 44(5):737-743. PubMed ID: 32842065
[TBL] [Abstract][Full Text] [Related]
3. Semantic Computed Tomography Features for Predicting BRCA1-associated Protein 1 and/or Tumor Protein p53 Gene Mutation Status in Clear Cell Renal Cell Carcinoma.
Wu XH; Zhu JM; Lin BH; Qiu QR; Ruan ZT; Wei Y; Xue XY; Zheng QS; Chen SH; Xu N
Int J Radiat Oncol Biol Phys; 2023 Jul; 116(3):666-675. PubMed ID: 36586494
[TBL] [Abstract][Full Text] [Related]
4. Correlation of CT imaging features and tumor size with Fuhrman grade of clear cell renal cell carcinoma.
Oh S; Sung DJ; Yang KS; Sim KC; Han NY; Park BJ; Kim MJ; Cho SB
Acta Radiol; 2017 Mar; 58(3):376-384. PubMed ID: 27235451
[TBL] [Abstract][Full Text] [Related]
5. RUNX3 methylation as a predictor for disease progression in patients with non-muscle-invasive bladder cancer.
Yan C; Kim YW; Ha YS; Kim IY; Kim YJ; Yun SJ; Moon SK; Bae SC; Kim WJ
J Surg Oncol; 2012 Mar; 105(4):425-30. PubMed ID: 22311819
[TBL] [Abstract][Full Text] [Related]
6. Radiogenomics of Clear Cell Renal Cell Carcinoma: Associations Between mRNA-Based Subtyping and CT Imaging Features.
Bowen L; Xiaojing L
Acad Radiol; 2019 May; 26(5):e32-e37. PubMed ID: 30064916
[TBL] [Abstract][Full Text] [Related]
7. Early-stage clear cell tubulopapillary renal cell carcinoma: imaging features and distinction from clear cell and papillary subtypes.
Mnatzakanian GN; Shinagare AB; Sahni VA; Hirsch MS; Silverman SG
Abdom Radiol (NY); 2016 Nov; 41(11):2187-2195. PubMed ID: 27383741
[TBL] [Abstract][Full Text] [Related]
8. CT-based radiomic model predicts high grade of clear cell renal cell carcinoma.
Ding J; Xing Z; Jiang Z; Chen J; Pan L; Qiu J; Xing W
Eur J Radiol; 2018 Jun; 103():51-56. PubMed ID: 29803385
[TBL] [Abstract][Full Text] [Related]
9. Presence of Intratumoral Calcifications and Vasculature Is Associated With Poor Overall Survival in Clear Cell Renal Cell Carcinoma.
Li C; Cen D; Liu Z; Liang C
J Comput Assist Tomogr; 2018; 42(3):418-422. PubMed ID: 29287026
[TBL] [Abstract][Full Text] [Related]
10. A Two-DNA Methylation Signature to Improve Prognosis Prediction of Clear Cell Renal Cell Carcinoma.
Shi S; Ye S; Wu X; Xu M; Zhuo R; Liao Q; Xi Y
Yonsei Med J; 2019 Nov; 60(11):1013-1020. PubMed ID: 31637882
[TBL] [Abstract][Full Text] [Related]
11. Runt-related transcription factor 3 methylation as a possible prognosticator in muscle-invasive bladder cancer.
Jeong P; Ha YS; Kim JS; Cho IC; Kim WT; Kim YJ; Yi Kim I; Yun SJ; Lee SC; Cha EJ; Kim WJ
Cancer Biomark; 2011; 10(5):205-11. PubMed ID: 22699781
[TBL] [Abstract][Full Text] [Related]
12. Computed tomography-based radiomics prediction of CTLA4 expression and prognosis in clear cell renal cell carcinoma.
He H; Jin Z; Dai J; Wang H; Sun J; Xu D
Cancer Med; 2023 Mar; 12(6):7627-7638. PubMed ID: 36397666
[TBL] [Abstract][Full Text] [Related]
13. Integrative radiogenomics analysis for predicting molecular features and survival in clear cell renal cell carcinoma.
Zeng H; Chen L; Wang M; Luo Y; Huang Y; Ma X
Aging (Albany NY); 2021 Mar; 13(7):9960-9975. PubMed ID: 33795526
[TBL] [Abstract][Full Text] [Related]
14. Noninvasive Fuhrman grading of clear cell renal cell carcinoma using computed tomography radiomic features and machine learning.
Nazari M; Shiri I; Hajianfar G; Oveisi N; Abdollahi H; Deevband MR; Oveisi M; Zaidi H
Radiol Med; 2020 Aug; 125(8):754-762. PubMed ID: 32193870
[TBL] [Abstract][Full Text] [Related]
15. Methylation of the RUNX3 promoter as a potential prognostic marker for bladder tumor.
Kim EJ; Kim YJ; Jeong P; Ha YS; Bae SC; Kim WJ
J Urol; 2008 Sep; 180(3):1141-5. PubMed ID: 18639281
[TBL] [Abstract][Full Text] [Related]
16. Small (<4 cm) clear cell renal cell carcinoma: correlation between CT findings and histologic grade.
Choi SY; Sung DJ; Yang KS; Kim KA; Yeom SK; Sim KC; Han NY; Park BJ; Kim MJ; Cho SB; Lee JH
Abdom Radiol (NY); 2016 Jun; 41(6):1160-9. PubMed ID: 27040407
[TBL] [Abstract][Full Text] [Related]
17. Baseline perfusion CT parameters as potential biomarkers in predicting long-term prognosis of localized clear cell renal cell carcinoma.
Wang Y; Cui L; Zhang J; Zhang L; Zhang J; Zhao X; Chen Y
Abdom Radiol (NY); 2019 Oct; 44(10):3370-3376. PubMed ID: 31399787
[TBL] [Abstract][Full Text] [Related]
18. A Four-Gene Promoter Methylation Marker Panel Consisting of
van Vlodrop IJH; Joosten SC; De Meyer T; Smits KM; Van Neste L; Melotte V; Baldewijns MMLL; Schouten LJ; van den Brandt PA; Jeschke J; Yi JM; Schuebel KE; Ahuja N; Herman JG; Aarts MJ; Bosman FT; Van Criekinge W; van Engeland M
Clin Cancer Res; 2017 Apr; 23(8):2006-2018. PubMed ID: 27756787
[No Abstract] [Full Text] [Related]
19. DNA methylation status defines clinicopathological parameters including survival for patients with clear cell renal cell carcinoma (ccRCC).
Evelönn EA; Degerman S; Köhn L; Landfors M; Ljungberg B; Roos G
Tumour Biol; 2016 Aug; 37(8):10219-28. PubMed ID: 26831665
[TBL] [Abstract][Full Text] [Related]
20. Prediction of Fuhrman nuclear grade for clear cell renal carcinoma by a multi-information fusion model that incorporates CT-based features of tumor and serum tumor associated material.
Zhang Y; Sun Z; Ma H; Wang C; Zhang W; Liu J; Li M; Zhang Y; Guo H; Ba X
J Cancer Res Clin Oncol; 2023 Nov; 149(17):15855-15865. PubMed ID: 37672076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
